Clinical Trial

Endoscopic Resection of Gastrointestinal Neoplasms

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated October 3, 2025 (before its estimated December 2025 completion). Its status may not reflect the trial's current state.
Summary
The study aims to retrospectively investigate the endoscopic resection procedures of cancerous and precancerous lesions of the upper and lower digestive tract in order to evaluate the efficacy and safety outcomes and to compare different resection techniques. In particular, the resection techniques investigated will be mucosectomy, en bloc and piecemeal, endoscopic submucosal dissection (ESD) and its variants, full-thickness resection. The anatomical districts involved will be the esophagus, stomach, duodenum, colon and rectum.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2021-02-28; most recent amendment 2025-09-30.
Status change: Not Yet Recruiting → Recruiting 2021-07-19
Status change: Recruiting → Not Yet Recruiting 2021-03-11
Trial Details
NCT Number NCT04780256
Lead Sponsor Azienda USL Reggio Emilia - IRCCS
Conditions Endoscopic Mucosal Resection, Endoscopic Submucosal Dissection, Gastric Neoplasm, Colonic Neoplasms, Esophageal Neoplasms, Duodenal Neoplasms
Enrollment 2,000 participants
Start Date 2021-03-15
Primary Completion 2025-12 (estimated)
Study Completion 2025-12 (estimated)
Updated on ClinicalTrials.gov 2025-10-03